Nomura Asset Management Co. Ltd. Acquires 300 Shares of Solventum Co. (NYSE:SOLV)

Nomura Asset Management Co. Ltd. grew its stake in Solventum Co. (NYSE:SOLV) by 0.7% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 44,741 shares of the company’s stock after purchasing an additional 300 shares during the period. Nomura Asset Management Co. Ltd.’s holdings in Solventum were worth $2,956,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also modified their holdings of SOLV. Modus Advisors LLC acquired a new position in Solventum during the fourth quarter worth $25,000. Stonebridge Financial Group LLC bought a new stake in shares of Solventum in the 4th quarter worth about $26,000. Crews Bank & Trust acquired a new stake in shares of Solventum during the 4th quarter worth about $32,000. Synergy Asset Management LLC bought a new position in Solventum during the 4th quarter valued at about $35,000. Finally, Spire Wealth Management bought a new stake in Solventum during the fourth quarter worth about $37,000.

Analyst Ratings Changes

Several brokerages have recently commented on SOLV. Wells Fargo & Company boosted their target price on Solventum from $73.00 to $75.00 and gave the stock an “equal weight” rating in a report on Friday, February 28th. Mizuho increased their target price on Solventum from $70.00 to $82.00 and gave the stock a “neutral” rating in a report on Monday, March 3rd. Piper Sandler upped their price target on shares of Solventum from $75.00 to $84.00 and gave the stock a “neutral” rating in a research report on Friday, February 28th. Morgan Stanley raised their price objective on shares of Solventum from $73.00 to $80.00 and gave the company an “equal weight” rating in a research report on Wednesday, March 5th. Finally, The Goldman Sachs Group upped their target price on shares of Solventum from $63.00 to $71.00 and gave the stock a “sell” rating in a research report on Monday, March 3rd. One investment analyst has rated the stock with a sell rating, eight have issued a hold rating and one has issued a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $79.86.

Solventum Stock Performance

Shares of SOLV stock opened at $76.54 on Thursday. The stock has a 50-day moving average of $75.66 and a 200-day moving average of $72.00. Solventum Co. has a one year low of $47.16 and a one year high of $85.92. The stock has a market cap of $13.24 billion and a PE ratio of 27.83. The company has a debt-to-equity ratio of 2.45, a current ratio of 1.15 and a quick ratio of 0.83.

About Solventum

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.